BCM
ABBV icon

Boreal Capital Management’s AbbVie ABBV Stock Holding History

Boreal Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$252K Sell
1,001
-969
-49% -$208K 0.19% 102
2026
Q1 		$428K Buy
1,970
+1
+0.1% +$222 0.35% 72
2025
Q4 		$450K Hold
1,969
– – 0.34% 78
2025
Q3 		$456K Buy
1,969
+36
+2% +$7.33K 0.37% 77
2025
Q2 		$359K Buy
+1,933
New +$359K 0.3% 93

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Boreal Capital Management's ABBV Position: Q2 2026 in Review

Boreal Capital Management reduced its AbbVie (ABBV) stake by 49% in Q2 2026, selling an estimated $208K and leaving 1,001 shares worth $252K. The position accounts for 0.19% of the portfolio, ranked #102.

Boreal Capital Management first reported a position in ABBV in Q2 2025 and has held it in 5 quarters since. The position peaked at $456K in Q3 2025. 4,221 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Boreal Capital Management held 1,001 shares of AbbVie worth $252K as of Q2 2026.
  • Boreal Capital Management sold 969 AbbVie shares in Q2 2026, an estimated $208K.
  • AbbVie made up 0.19% of Boreal Capital Management's portfolio in Q2 2026, its #102 holding.
  • Boreal Capital Management first reported a position in AbbVie in Q2 2025 and has held it in 5 quarters since.
  • Boreal Capital Management's AbbVie position peaked at $456K in Q3 2025.
  • 4,221 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Boreal Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.